uMotif
PrivateLast Round
Growth Equity
May 25, 2022
Total Funding Raised
$32.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
uMotif operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Growth Equity round in May 2022.
uMotif is a healthcare technology company that provides a patient-centric eCOA/ePRO and engagement platform for clinical research and real-world studies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
uMotif Comparables
Compare uMotif with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YPrime | 86% | |
| Clinical Ink | 85% | |
| Medrio | 84% |
For institutional investors. Book with your work email.
uMotif Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 25, 2022 | ||||
| Series A | Sep 3, 2020 | ||||
| VC Round | Jun 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
uMotif Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Athyrium Capital Management | Growth Equity |
| Albion Capital | VC Round |
| Albion Capital | Growth Equity, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
COO Andrea Valente promoted to CEO, succeeding Steve Rosenberg.
- Apr 23, 2026
Steve Rosenberg, the company's CEO, is retiring.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 10, 2026
In H1 '26, uMotif Limited's Chief Scientific Officer Florence Mowlem PhD wins the 2026 PCMG Outsourcing Trailblazer of the Year Award.
For institutional investors. Book with your work email.
uMotif Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about uMotif's valuation, stock price, and market status.
Is uMotif a public or private company?
uMotif is a private company.
What is the current stock price of uMotif?
uMotif is a private company, so its shares have no public market price. Caplight tracks uMotif's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is uMotif worth (valuation)?
Valuation information for uMotif is not publicly available.
Can I buy uMotif stock?
uMotif shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was uMotif's last funding round?
uMotif's most recent funding round was Growth Equity on May 25, 2022.
Who are the main investors in uMotif?
Key investors in uMotif include Athyrium Capital Management, Albion Capital, Albion Capital.
Will uMotif IPO soon?
No public IPO plans have been announced for uMotif.
How can I track uMotif secondary market activity?
Caplight tracks bids, offers, and trades in uMotif's shares on secondary markets.